Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407173
Status:
COMPLETED
Last Update Posted:
2008-04-14
First Post:
2006-11-29
Brief Title:
Study to Evaluate the Effects of Age Gender on PK Safety Tolerability of HCV-796 Administered to Healthy Subjects
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open-Label Single-Dose Parallel Group Study to Evaluate the Effects of Age and Gender on the Pharmacokinetics Safety and Tolerability of HCV-796 Administered Orally to Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an open-label single-dose parallel group study to evaluate the effects of age and gender on the pharmacokinetics safety and tolerability of HCV-796 administered orally to healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None